It’s time for your Daily Hit of cannabis financial news for June 8, 2021.
On The Site
It is truly a labor of love to put out a regular print publication. A combination of writers, artists, printers, and distributors. Not to mention the trying to sell the advertising to pay for all of this. While most of us consume our media on our phones, there is something deeply satisfying when reading a story on paper accompanied by beautiful photographs. The pictures on our phones just don’t have the same impact. Plus, who doesn’t love to see themselves or their company featured in a print publication? So with that said, we put together a list of the top cannabis industry print publications. They are listed in alphabetical order.
Tilray, Inc. (NASDAQ: TLRY) is launching a new medical marijuana product called Symbios. The company said that the new brand was developed to provide a broader product at a better price point. Potency will range from 15%-18% and all flower is grown in the same Greenhouse as Aphria-branded flower. Current strains include Nordle, Treasure Island, Sour Kush, Jack Herer, Exodus Cheese, and Grower’s Blend (milled flower).
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) reports that its R&D team has discovered over 40 compounds with pharmacological potential in mushrooms. Mydecine said that it has screened over 25 mushroom species, including various varieties of p. cubensis, and has selected and analyzed over 40 unique compounds found throughout the various species. Of these compounds, a large majority appear to have never been reported before and could be vital to the critical effects of naturally-sourced mushrooms on human health and wellbeing as well as synergistic effects with pure psilocybin.
The cannabis industry’s proof was in 2020’s revenue, but Brightfield’s newest report shows consumer